Christopher W. Fulton

Array ( [id] => 3935976 [patent_doc_number] => 05939557 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => 'Inhibitors of farnesyl-protein transferase' [patent_app_type] => 1 [patent_app_number] => 8/823919 [patent_app_country] => US [patent_app_date] => 1997-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17461 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939557.pdf [firstpage_image] =>[orig_patent_app_number] => 823919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4035798 [patent_doc_number] => 05942600 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-24 [patent_title] => 'Seryl-lysyl-based peptide and peptidomimetic inhibitors of N-myristoyl transferase as anti-infective agents' [patent_app_type] => 1 [patent_app_number] => 8/823101 [patent_app_country] => US [patent_app_date] => 1997-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 88135 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 390 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/942/05942600.pdf [firstpage_image] =>[orig_patent_app_number] => 823101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3970576 [patent_doc_number] => 05916560 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-29 [patent_title] => 'Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith' [patent_app_type] => 1 [patent_app_number] => 8/821400 [patent_app_country] => US [patent_app_date] => 1997-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 36 [patent_no_of_words] => 10242 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/916/05916560.pdf [firstpage_image] =>[orig_patent_app_number] => 821400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933468 [patent_doc_number] => 05929027 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Physiologically active polypeptide-containing pharmaceutical composition' [patent_app_type] => 1 [patent_app_number] => 8/815574 [patent_app_country] => US [patent_app_date] => 1997-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5070 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/929/05929027.pdf [firstpage_image] =>[orig_patent_app_number] => 815574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3888455 [patent_doc_number] => 05777077 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Automated allyl deprotection in solid-phase synthesis' [patent_app_type] => 1 [patent_app_number] => 8/803557 [patent_app_country] => US [patent_app_date] => 1997-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 10249 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/777/05777077.pdf [firstpage_image] =>[orig_patent_app_number] => 803557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3939194 [patent_doc_number] => 05981470 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Uterine fibroid treatment' [patent_app_type] => 1 [patent_app_number] => 8/750220 [patent_app_country] => US [patent_app_date] => 1997-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 20 [patent_no_of_words] => 4814 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981470.pdf [firstpage_image] =>[orig_patent_app_number] => 750220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3984213 [patent_doc_number] => 05958964 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Use of melatonin to prevent cytotoxic effects of amyloid beta protein' [patent_app_type] => 1 [patent_app_number] => 8/801301 [patent_app_country] => US [patent_app_date] => 1997-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 10 [patent_no_of_words] => 6445 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958964.pdf [firstpage_image] =>[orig_patent_app_number] => 801301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3995102 [patent_doc_number] => 05892043 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Camptothecin derivatives' [patent_app_type] => 1 [patent_app_number] => 8/773182 [patent_app_country] => US [patent_app_date] => 1996-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11366 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/892/05892043.pdf [firstpage_image] =>[orig_patent_app_number] => 773182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1451281 [patent_doc_number] => 06455671 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Thrombin inhibitors, the preparation and use thereof' [patent_app_type] => B1 [patent_app_number] => 08/682604 [patent_app_country] => US [patent_app_date] => 1996-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41969 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 856 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455671.pdf [firstpage_image] =>[orig_patent_app_number] => 08682604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3957757 [patent_doc_number] => 05936069 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Process for producing improved soy protein concentrate from genetically-modified soybeans' [patent_app_type] => 1 [patent_app_number] => 8/760037 [patent_app_country] => US [patent_app_date] => 1996-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8982 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/936/05936069.pdf [firstpage_image] =>[orig_patent_app_number] => 760037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3808990 [patent_doc_number] => 05811401 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Advanced glycosylation endproducts and methods of use therefor' [patent_app_type] => 1 [patent_app_number] => 8/757234 [patent_app_country] => US [patent_app_date] => 1996-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4407 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811401.pdf [firstpage_image] =>[orig_patent_app_number] => 757234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3884427 [patent_doc_number] => 05834042 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Method for isolating whey proteins' [patent_app_type] => 1 [patent_app_number] => 8/619666 [patent_app_country] => US [patent_app_date] => 1996-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6494 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/834/05834042.pdf [firstpage_image] =>[orig_patent_app_number] => 619666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3968988 [patent_doc_number] => 05886147 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Compounds useful for the synthesis of dolastatin analogs' [patent_app_type] => 1 [patent_app_number] => 8/737279 [patent_app_country] => US [patent_app_date] => 1996-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2990 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/886/05886147.pdf [firstpage_image] =>[orig_patent_app_number] => 737279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4024343 [patent_doc_number] => 05925731 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'Endothelin antagonist peptides' [patent_app_type] => 1 [patent_app_number] => 8/732289 [patent_app_country] => US [patent_app_date] => 1996-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15586 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925731.pdf [firstpage_image] =>[orig_patent_app_number] => 732289 [rel_patent_id] =>[rel_patent_doc_number] =>)